BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joshi N, Mcaree M, Klimowich K, Cahill K, Janora D. Oral Candidiasis in a Migraine Patient Taking Erenumab and Galcanezumab: a Case Report. SN Compr Clin Med 2020;2:658-61. [DOI: 10.1007/s42399-020-00300-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Benemei S, Bentivegna E, Martelletti P. Positioning the new drugs for migraine. Expert Opin Drug Metab Toxicol 2022;18:1-3. [PMID: 35240909 DOI: 10.1080/17425255.2022.2049236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
2 González-Hernández A, Marichal-Cancino BA, Villalón CM. The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events. Expert Opin Drug Metab Toxicol 2021;17:1223-35. [PMID: 34535065 DOI: 10.1080/17425255.2021.1982892] [Reference Citation Analysis]
3 Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf 2021;20:623-5. [PMID: 33749470 DOI: 10.1080/14740338.2021.1907342] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
4 Martelletti P. Combination therapy in migraine: asset or issue? Expert Rev Neurother 2020;20:995-6. [PMID: 32896181 DOI: 10.1080/14737175.2020.1821655] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
5 Frattale I, Ornello R, Pistoia F, Caponnetto V, Colangeli E, Sacco S. Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab. Intern Emerg Med 2021;16:227-8. [PMID: 32557089 DOI: 10.1007/s11739-020-02407-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]